Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Somatomedin B and thrombospondin type 1 domain containing pseudogene (SBSPON pseudogene)
- Target
- SBSPON pseudogene
- Molecular classification
- Pseudogene
01
Overview
Somatomedin B and thrombospondin type 1 domain containing pseudogene (ENSG00000283529) is a non-protein-coding sequence classified as a pseudogene. Pseudogenes resemble functional genes but typically do not encode proteins due to mutations or genomic rearrangements. While some pseudogenes can be transcribed and play roles in regulating expression of related genes—acting through antisense transcripts, small interfering RNAs, or competing for regulatory factors—the SBSPON pseudogene has not been reported as druggable or directly implicated in disease. Most pseudogenes are not considered therapeutic targets, but ongoing research is investigating whether particular pseudogenes have biological or disease relevance through RNA-mediated mechanisms.
- Other names
- SBSPON pseudogeneSomatomedin B and thrombospondin type 1 domain containing (pseudogene)ENSG00000283529
02
Biological functions
Genetic regulation (by noncoding RNA mechanisms, if expressed)Possible competition for gene expression regulation (via RNA, if functional)
03
Disease associations
Other (pseudogenes as a class may have indirect roles in disease through regulatory effects, but specific roles for SBSPON pseudogene have not been described)
Beyond the preview
Go deeper on Somatomedin B and thrombospondin type 1 domain containing pseudogene (SBSPON pseudogene).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Somatomedin B and thrombospondin type 1 domain containing pseudogene (SBSPON pseudogene).